Zambia: Tib Widens Treatment options for AIDS – tech2.org

Zambia: Tib Widens Treatment options for AIDS



[ad_1]

By Charles Simengwa

The Tian Immunity Booster (TIB) has continued to play a pivotal role in the fight against HIV / AIDS in Africa, as evidenced by its growing recognition on the continent.

Over the last decade, there have been remarkable steps in medical research that make it possible for everyone to imagine a world without HIV / AIDS.

It is well known that medical researchers are looking for ways to achieve universal treatment of HIV / AIDS in the African continent through the effective implementation of the recommendation & # 39; Treat All & # 39; of the World Health Organization (WHO) of 2016.

This is important because, according to UNAIDS, there were approximately 36.7 million people around the world living with HIV / AIDS at the end of 2016.

these, 2.1 million were children under 15 years of age. It is estimated that 1.8 million people worldwide contracted HIV in 2016, which resulted in around 5,000 new infections per day.

Zambia, which participates in the commemoration of World AIDS Day 2017, has taken ambitious measures to reverse the trend of infections, as well as promoting healthy lifestyles for those who have already contracted the virus.

This is necessary because in Zambia, more than 1.2 million people are living with HIV and more than one million have died from the disease.

"This is despite the fact that the virus was only identified in 1984, making HIV one of the most destructive pandemics in human history," says Stanslous Ngosa, head of communications and external relations of the Ministry of Health.

World AIDS Day, an annual event commemorated around the world on December 1, offers an opportunity for people to join in the fight against the pandemic and to show their support for people living with HIV.

It is also used to remember those who have died of AIDS-related illnesses.

Zambia has changed the date for the commemoration of this year, from December 1 to December 11, which will be celebrated under the theme "End AIDS for 2030 begins with me".

According to Mr. Ngosa, the date change aims to expand participation throughout the country following the launching of the Universal HIV Test, Advice and Treatment by President Edgar Lungu on August 15 of this year.

A vision as ambitious as ending AIDS by 2030 suggests use of broader approaches, including herbal medicine.

A good example is the TIB, invented by Tian Shengxun, a doctor since 1982 when he finished the university study.

UNAIDS indicates that it is generally accepted that antiretroviral therapy (ART) should be delivered as part of an integrated approach to prevention and care services.

These include counseling and voluntary testing, prevention of mother-to-child transmission, diagnosis and treatment of opportunistic infections and other HIV-related diseases, and other prevention, care and social support services.

Similarly, a 2003 report on the provision of ART in resource-limited settings, prepared by the Health Systems Resource Center for the United Kingdom The Department for International Development, in collaboration with WHO, noted the severe tension of the pandemic in national health budgets.

The available evidence suggests that the HIV / AIDS epidemic is increasing the demand for health systems already under pressure and undermining the ability of systems to provide services through the erosion of workers in the health sector.

Attempts to address the systemic impact of HIV / AIDS remain fragmented, confined to a few countries, and lack the support of a coherent framework of policies and resources.

The report notes that this will become more critical as countries move towards the extension of ART, since the effective and efficient provision of ART will require good functioning systems.

Adequate infrastructure is needed, including clinical care, laboratories and pharmacies, to administer ART.

Limited infrastructure of health services has been identified as an important limitation to the expansion of ART in many low-income countries. 19659024] In Mozambique, the current infrastructure is inadequate to meet the demands of a large-scale program, and the 2003 strategic plan to expand identified areas that require attention, including rehabilitation of facilities, equipment procurement and HIV / AIDS services of laboratory and blood bank.

Antiretroviral (ARV) drug programs need a regular and timely supply of quality medicines and supplies at competitive prices.

This should also include laboratory reagents and related supplies, and medications for HIV-related diseases.

"The system must be able to mitigate uncertainties in financing and minimize the risks of interrupted supplies, as continuous treatment is critical to minimize the development of resistance."

"A safe, leak-free supply chain and interruptions, is also essential along with a strict control of inventory levels and safe storage facilities, "the report notes.

There is already an illegal market in antiretrovirals in many countries, and the leakage of drugs provided by the government could worsen the risk of misuse of ARV and development of resistance.

In Zambia, the Network of people living with HIV / AIDS this year protested against the difficulties that were sometimes facing access to ARVs. [19659008] In this context, it is important that any country adopts all available options to prevent a further explosion of the pandemic.

Professor Tian, ​​based in Nairobi, Kenya, says that the fight against HIV / AIDS could be more effective if infected people receive a combination of conventional ARVs and traditional medicines

TIB, which has been registered by the Pharmacy and Poiso The Board of the Ministry of Health of Kenya is doing wonders for people living with HIV / AIDS, even in cases of failure of antiretroviral treatment.

A recent report by the Ministry of Health of Kenya and the United Nations states that "unacceptably" high rates of ARV failure among refugees and residents of Kakuma, in the northern part of the East African country.

] Tian Immunity Booster is a 100 percent extraction of herbs made in the form of tablets or capsules.

has obtained international certificates of invention patents from China, Africa and the European Union (EU).

Includes herbal products cigars with sugar-coated tablets whose active ingredients are extracted from 100 percent herbs using modern technology.

Prof. Tian, ​​in an interview from Nairobi, said that TIB has multiple targets for controlling viral load.

] Particularly blocks the fusion that takes place between HIV and CD4 cells, which implies that it can stop HIV from affecting CD4 cells that are inhibitory to the fusion.

TIB has proved useful in the fight against opportunistic infections such as tuberculosis (TB) and even multidrug-resistant tuberculosis (MDR-TB), which is a global threat.

MDR-TB threatens to kill 75 million people by the year 2050, at a cost of US $ 16.7 billion, which is the equivalent of the annual production of the EU, a UK parliamentary group declared a time.

For this reason, and as a cure for AIDS remains elusive: African countries should expand their treatment options and resort to herbal medicines such as TIB

[ad_2]
Source link

Leave a Reply

Your email address will not be published.